Mechanisms of electrolyte transport across the endometrium. I. Regulation by PGF2 alpha and cAMP.
The purpose of this study was to characterize the transport mechanisms in endometrial epithelial cells that are responsible for regulation of Na and K concentrations in uterine luminal fluid. Porcine endometrial tissues were mounted in Ussing chambers and bathed in plasmalike Ringer solution. The mean basal short-circuit current (Isc) was 40 microA/cm2, and the mean tissue conductance was 3.6 mS/cm2. Addition of amiloride to the luminal solution inhibited 86% of the basal Isc. Concentration-response experiments using amiloride analogues showed a rank order of potency of benzamil > amiloride > 5-(N-methyl-N-isobutyl)-amiloride in blocking the Isc, with no response to ethylisopropylamiloride. Na channel immunoreactivity was localized to the apical membrane of surface epithelial cells. The Na-to-K selectivity ratio of the amiloride-sensitive Na channel was calculated to be 6.4:1. Prostaglandin (PG) F2 alpha or 8-(chlorophenylthio)-adenosine 3',5'-cyclic monophosphate (CPT-cAMP) added to the luminal solution stimulated a twofold increase in Isc that was inhibited by pretreatment with amiloride. Experiments using both amphotericin B-permeabilized tissues and intact tissues showed that PGF2 alpha and cAMP increased Na absorption by activation of basolateral K channels. Treatment of the luminal solution with 4-aminopyridine produced an effect on Isc that was consistent with block of K secretion and a subsequent decrease in Na absorption. These experiments showed that Na and K transport are tightly coupled processes occurring under basal conditions in surface endometrial epithelial cells and that these processes are regulated by PGF2 alpha and cAMP.
Vetter
A E
AE
Department of Veterinary PathoBiology, University of Minnesota, St. Paul 55108, USA.
O'Grady
S M
SM
D015761:4-Aminopyridine / Q000494:pharmacology; D000584:Amiloride / Q000031:analogs & derivatives / Q000494:pharmacology; D000818:Animals; D001464:Barium / Q000494:pharmacology; D001692:Biological Transport; D000242:Cyclic AMP / Q000031:analogs & derivatives / Q000494:pharmacology / Q000502:physiology*; D015237:Dinoprost / Q000494:pharmacology / Q000502:physiology*; D004553:Electric Conductivity; D004573:Electrolytes / Q000378:metabolism*; D004717:Endometrium / Q000378:metabolism* / Q000502:physiology; D005260:Female; D007150:Immunohistochemistry; D010539:Permeability; D011188:Potassium / Q000378:metabolism; D015222:Sodium Channels / Q000378:metabolism; D013552:Swine; D013873:Thionucleotides / Q000494:pharmacology
D004573:Electrolytes; D015222:Sodium Channels; D013873:Thionucleotides; D001464:Barium; C015929:8-((4-chlorophenyl)thio)cyclic-3',5'-AMP; D000584:Amiloride; D015237:Dinoprost; D015761:4-Aminopyridine; D000242:Cyclic AMP; D011188:Potassium